In conclusion, this study provides compelling evidence that apoA-I increases glucose disposal in skeletal muscle, thus supporting a role for HDL in reducing insulin resistance and improving glycaemic control in people with type 2 diabetes. This evidence concerns the gene APOA1 and type 2 diabetes mellitus.